Gary Earl Duncan, Ph.D. - Publications

University of North Carolina - Chapel Hill University of North Carolina, Chapel Hill, Chapel Hill, NC 

73 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2012 Duncan GE, Koller BH, Moy SS. Effects of the selective kainate receptor antagonist ACET on altered sensorimotor gating in a genetic model of reduced NMDA receptor function. Brain Research. 1443: 98-105. PMID 22297176 DOI: 10.1016/J.Brainres.2012.01.009  0.374
2010 Duncan GE, Inada K, Koller BH, Moy SS. Increased sensitivity to kainic acid in a genetic model of reduced NMDA receptor function. Brain Research. 1307: 166-76. PMID 19840778 DOI: 10.1016/J.Brainres.2009.10.023  0.363
2009 Duncan GE, Inada K, Farrington JS, Koller BH, Moy SS. Neural activation deficits in a mouse genetic model of NMDA receptor hypofunction in tests of social aggression and swim stress. Brain Research. 1265: 186-95. PMID 19232330 DOI: 10.1016/J.Brainres.2009.02.002  0.367
2008 Lieberman JA, Bymaster FP, Meltzer HY, Deutch AY, Duncan GE, Marx CE, Aprille JR, Dwyer DS, Li XM, Mahadik SP, Duman RS, Porter JH, Modica-Napolitano JS, Newton SS, Csernansky JG. Antipsychotic drugs: comparison in animal models of efficacy, neurotransmitter regulation, and neuroprotection. Pharmacological Reviews. 60: 358-403. PMID 18922967 DOI: 10.1124/Pr.107.00107  0.32
2008 Duncan GE, Inada K, Farrington JS, Koller BH. Seizure responses and induction of Fos by the NMDA agonist (tetrazol-5-yl)glycine in a genetic model of NMDA receptor hypofunction. Brain Research. 1221: 41-8. PMID 18550035 DOI: 10.1016/J.Brainres.2008.05.001  0.344
2007 Inada K, Farrington JS, Moy SS, Koller BH, Duncan GE. Assessment of NMDA receptor activation in vivo by Fos induction after challenge with the direct NMDA agonist (tetrazol-5-yl)glycine: effects of clozapine and haloperidol. Journal of Neural Transmission (Vienna, Austria : 1996). 114: 899-908. PMID 17318306 DOI: 10.1007/S00702-007-0628-5  0.412
2006 Duncan GE, Moy SS, Lieberman JA, Koller BH. Typical and atypical antipsychotic drug effects on locomotor hyperactivity and deficits in sensorimotor gating in a genetic model of NMDA receptor hypofunction. Pharmacology, Biochemistry, and Behavior. 85: 481-91. PMID 17097724 DOI: 10.1016/J.Pbb.2006.09.017  0.349
2006 Marx CE, Shampine LJ, Duncan GE, VanDoren MJ, Grobin AC, Massing MW, Madison RD, Bradford DW, Butterfield MI, Lieberman JA, Morrow AL. Clozapine markedly elevates pregnenolone in rat hippocampus, cerebral cortex, and serum: candidate mechanism for superior efficacy? Pharmacology, Biochemistry, and Behavior. 84: 598-608. PMID 16962649 DOI: 10.1016/J.Pbb.2006.07.026  0.343
2006 Moy SS, Perez A, Koller BH, Duncan GE. Amphetamine-induced disruption of prepulse inhibition in mice with reduced NMDA receptor function. Brain Research. 1089: 186-94. PMID 16638606 DOI: 10.1016/J.Brainres.2006.03.073  0.347
2006 Duncan GE, Moy SS, Lieberman JA, Koller BH. Effects of haloperidol, clozapine, and quetiapine on sensorimotor gating in a genetic model of reduced NMDA receptor function. Psychopharmacology. 184: 190-200. PMID 16362405 DOI: 10.1007/S00213-005-0214-1  0.348
2005 Duncan GE, Kohn H. The novel antiepileptic drug lacosamide blocks behavioral and brain metabolic manifestations of seizure activity in the 6 Hz psychomotor seizure model. Epilepsy Research. 67: 81-7. PMID 16214306 DOI: 10.1016/J.Eplepsyres.2005.08.009  0.333
2005 Miyamoto S, Duncan GE, Marx CE, Lieberman JA. Treatments for schizophrenia: a critical review of pharmacology and mechanisms of action of antipsychotic drugs. Molecular Psychiatry. 10: 79-104. PMID 15289815 DOI: 10.1038/Sj.Mp.4001556  0.301
2004 Miyamoto S, Snouwaert JN, Koller BH, Moy SS, Lieberman JA, Duncan GE. Amphetamine-induced Fos is reduced in limbic cortical regions but not in the caudate or accumbens in a genetic model of NMDA receptor hypofunction. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 29: 2180-8. PMID 15467708 DOI: 10.1038/Sj.Npp.1300548  0.378
2004 Duncan GE, Moy SS, Perez A, Eddy DM, Zinzow WM, Lieberman JA, Snouwaert JN, Koller BH. Deficits in sensorimotor gating and tests of social behavior in a genetic model of reduced NMDA receptor function. Behavioural Brain Research. 153: 507-19. PMID 15265649 DOI: 10.1016/J.Bbr.2004.01.008  0.316
2003 Duncan GE, Miyamoto S, Lieberman JA. Chronic administration of haloperidol and olanzapine attenuates ketamine-induced brain metabolic activation. The Journal of Pharmacology and Experimental Therapeutics. 305: 999-1005. PMID 12626664 DOI: 10.1124/Jpet.102.048140  0.425
2003 Marx CE, VanDoren MJ, Duncan GE, Lieberman JA, Morrow AL. Olanzapine and clozapine increase the GABAergic neuroactive steroid allopregnanolone in rodents. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 28: 1-13. PMID 12496935 DOI: 10.1038/Sj.Npp.1300015  0.351
2002 Duncan G, Miyamoto S, Gu H, Lieberman J, Koller B, Snouwaert J. Alterations in regional brain metabolism in genetic and pharmacological models of reduced NMDA receptor function. Brain Research. 951: 166-76. PMID 12270494 DOI: 10.1016/S0006-8993(02)03156-6  0.426
2001 Knapp DJ, Braun CJ, Duncan GE, Qian Y, Fernandes A, Crews FT, Breese GR. Regional specificity of ethanol and NMDA action in brain revealed with FOS-like immunohistochemistry and differential routes of drug administration. Alcoholism, Clinical and Experimental Research. 25: 1662-72. PMID 11707641 DOI: 10.1111/J.1530-0277.2001.Tb02173.X  0.41
2001 Miyamoto S, Mailman RB, Lieberman JA, Duncan GE. Blunted brain metabolic response to ketamine in mice lacking D(1A) dopamine receptors. Brain Research. 894: 167-80. PMID 11251190 DOI: 10.1016/S0006-8993(01)01991-6  0.376
2000 Moy SS, Knapp DJ, Duncan GE, Breese GR. Enhanced ultrasonic vocalization and Fos protein expression following ethanol withdrawal: effects of flumazenil. Psychopharmacology. 152: 208-15. PMID 11057525 DOI: 10.1007/S002130000507  0.327
2000 Marx CE, Duncan GE, Gilmore JH, Lieberman JA, Morrow AL. Olanzapine increases allopregnanolone in the rat cerebral cortex. Biological Psychiatry. 47: 1000-4. PMID 10838068 DOI: 10.1016/S0006-3223(99)00305-4  0.363
2000 Duncan GE, Miyamoto S, Leipzig JN, Lieberman JA. Comparison of the effects of clozapine, risperidone, and olanzapine on ketamine-induced alterations in regional brain metabolism. The Journal of Pharmacology and Experimental Therapeutics. 293: 8-14. PMID 10734147  0.309
2000 Miyamoto S, Leipzig JN, Lieberman JA, Duncan GE. Effects of ketamine, MK-801, and amphetamine on regional brain 2-deoxyglucose uptake in freely moving mice. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 22: 400-12. PMID 10700659 DOI: 10.1016/S0893-133X(99)00127-X  0.435
2000 Miyamoto S, Mailman R, Drago J, Lieberman J, Duncan G. 145. Blunted brain metabolic response to ketamine in mice lacking D1A dopamine receptors Biological Psychiatry. 47: S44. DOI: 10.1016/S0006-3223(00)00407-8  0.345
1999 Duncan GE, Miyamoto S, Leipzig JN, Lieberman JA. Comparison of brain metabolic activity patterns induced by ketamine, MK-801 and amphetamine in rats: support for NMDA receptor involvement in responses to subanesthetic dose of ketamine. Brain Research. 843: 171-83. PMID 10528123 DOI: 10.1016/S0006-8993(99)01776-X  0.439
1999 Duncan GE, Zorn S, Lieberman JA. Mechanisms of typical and atypical antipsychotic drug action in relation to dopamine and NMDA receptor hypofunction hypotheses of schizophrenia. Molecular Psychiatry. 4: 418-28. PMID 10523814 DOI: 10.1038/Sj.Mp.4000581  0.323
1999 Duncan GE, Sheitman BB, Lieberman JA. An integrated view of pathophysiological models of schizophrenia. Brain Research. Brain Research Reviews. 29: 250-64. PMID 10209235 DOI: 10.1016/S0165-0173(99)00002-8  0.347
1998 Lieberman JA, Mailman RB, Duncan G, Sikich L, Chakos M, Nichols DE, Kraus JE. Serotonergic basis of antipsychotic drug effects in schizophrenia. Biological Psychiatry. 44: 1099-117. PMID 9836014 DOI: 10.1016/S0006-3223(98)00187-5  0.32
1998 Duncan GE, Leipzig JN, Mailman RB, Lieberman JA. Differential effects of clozapine and haloperidol on ketamine-induced brain metabolic activation. Brain Research. 812: 65-75. PMID 9813244 DOI: 10.1016/S0006-8993(98)00926-3  0.441
1998 Moy SS, Duncan GE, Knapp DJ, Breese GR. Sensitivity to ethanol across development in rats: comparison to [3H]zolpidem binding. Alcoholism, Clinical and Experimental Research. 22: 1485-92. PMID 9802533 DOI: 10.1111/J.1530-0277.1998.Tb03940.X  0.356
1998 Duncan GE, Knapp DJ, Breese GR, Crews FT, Little KY. Species differences in regional patterns of 3H-8-OH-DPAT and 3H-zolpidem binding in the rat and human brain. Pharmacology, Biochemistry, and Behavior. 60: 439-48. PMID 9632227 DOI: 10.1016/S0091-3057(98)00018-5  0.427
1998 Knapp DJ, Duncan GE, Crews FT, Breese GR. Induction of Fos-like proteins and ultrasonic vocalizations during ethanol withdrawal: further evidence for withdrawal-induced anxiety. Alcoholism, Clinical and Experimental Research. 22: 481-93. PMID 9581657 DOI: 10.1111/J.1530-0277.1998.Tb03677.X  0.356
1998 Duncan GE, Moy SS, Knapp DJ, Mueller RA, Breese GR. Metabolic mapping of the rat brain after subanesthetic doses of ketamine: potential relevance to schizophrenia. Brain Research. 787: 181-90. PMID 9518601 DOI: 10.1016/S0006-8993(97)01390-5  0.378
1996 Duncan GE, Knapp DJ, Breese GR. Neuroanatomical characterization of Fos induction in rat behavioral models of anxiety. Brain Research. 713: 79-91. PMID 8724978 DOI: 10.1016/0006-8993(95)01486-1  0.378
1996 Little KY, Kirkman JA, Duncan GE. Beta-adrenergic receptor subtypes in human pineal gland. Journal of Pineal Research. 20: 15-20. PMID 8648557 DOI: 10.1111/J.1600-079X.1996.Tb00233.X  0.346
1996 Duncan GE, Knapp DJ, Johnson KB, Breese GR. Functional classification of antidepressants based on antagonism of swim stress-induced fos-like immunoreactivity. The Journal of Pharmacology and Experimental Therapeutics. 277: 1076-89. PMID 8627519  0.33
1995 Duncan GE, Breese GR, Criswell HE, McCown TJ, Herbert JS, Devaud LL, Morrow AL. Distribution of [3H]zolpidem binding sites in relation to messenger RNA encoding the alpha 1, beta 2 and gamma 2 subunits of GABAA receptors in rat brain. Neuroscience. 64: 1113-28. PMID 7753379 DOI: 10.1016/0306-4522(94)00433-6  0.392
1995 Devaud LL, Morrow AL, Criswell HE, Breese GR, Duncan GE. Regional differences in the effects of chronic ethanol administration on [3H]zolpidem binding in rat brain. Alcoholism, Clinical and Experimental Research. 19: 910-4. PMID 7485838 DOI: 10.1111/J.1530-0277.1995.Tb00966.X  0.388
1995 Breese GR, Criswell HE, Duncan GE, Moy SS, Johnson KB, Wong DF, Mueller RA. Model for reduced brain dopamine in Lesch-Nyhan syndrome and the mentally retarded: Neurobiology of neonatal-6-hydroxydopamine-lesioned rats Mental Retardation and Developmental Disabilities Research Reviews. 1: 111-119. DOI: 10.1002/Mrdd.1410010207  0.363
1994 Duncan GE, Henson OW. Brain activity patterns in flying, echolocating bats (Pteronotus parnellii): assessment by high resolution autoradiographic imaging with [3H]2-deoxyglucose. Neuroscience. 59: 1051-70. PMID 8058119 DOI: 10.1016/0306-4522(94)90305-0  0.375
1994 Duncan GE, Knapp DJ, Little KY, Breese GR. Neuroanatomical specificity and dose dependence in the time course of imipramine-induced beta adrenergic receptor down-regulation in rat brain. The Journal of Pharmacology and Experimental Therapeutics. 271: 1699-704. PMID 7996487  0.319
1994 Schambra UB, Duncan GE, Breese GR, Fornaretto MG, Caron MG, Fremeau RT. Ontogeny of D1A and D2 dopamine receptor subtypes in rat brain using in situ hybridization and receptor binding. Neuroscience. 62: 65-85. PMID 7816213 DOI: 10.1016/0306-4522(94)90315-8  0.366
1993 Duncan GE, Breese GR, Criswell HE, Johnson KB, Schambra UB, Mueller RA, Caron MG, Fremeau RT. D1 dopamine receptor binding and mRNA levels are not altered after neonatal 6-hydroxydopamine treatment: evidence against dopamine-mediated induction of D1 dopamine receptors during postnatal development. Journal of Neurochemistry. 61: 1255-62. PMID 8376983 DOI: 10.1111/J.1471-4159.1993.Tb13616.X  0.399
1993 Duncan GE, Johnson KB, Breese GR. Topographic patterns of brain activity in response to swim stress: assessment by 2-deoxyglucose uptake and expression of Fos-like immunoreactivity. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 13: 3932-43. PMID 8366353 DOI: 10.1523/Jneurosci.13-09-03932.1993  0.381
1993 Little KY, Clark TB, Ranc J, Duncan GE. β-adrenergic receptor binding in frontal cortex from suicide victims Biological Psychiatry. 34: 596-605. PMID 8292688 DOI: 10.1016/0006-3223(93)90151-3  0.324
1993 Little KY, Kirkman JA, Carroll FI, Breese GR, Duncan GE. [125I]RTI-55 binding to cocaine-sensitive dopaminergic and serotonergic uptake sites in the human brain. Journal of Neurochemistry. 61: 1996-2006. PMID 8245956 DOI: 10.1111/J.1471-4159.1993.Tb07435.X  0.301
1993 Duncan GE, Paul IA, Breese GR. Neuroanatomical differences in the rate of beta-adrenergic receptor adaptation after repeated treatment with imipramine. Psychopharmacology Bulletin. 29: 401-7. PMID 8121968  0.615
1992 Duncan GE, Little KY, Kirkman JA, Kaldas RS, Stumpf WE, Breese GR. Autoradiographic characterization of [3H]imipramine and [3H]citalopram binding in rat and human brain: species differences and relationships to serotonin innervation patterns. Brain Research. 591: 181-97. PMID 1332802 DOI: 10.1016/0006-8993(92)91699-F  0.391
1992 Little KY, Duncan GE, Breese GR, Stumpf WE. Beta-adrenergic receptor binding in human and rat hypothalamus. Biological Psychiatry. 32: 512-22. PMID 1332783 DOI: 10.1016/0006-3223(92)90219-P  0.367
1991 Duncan GE, Paul IA, Fassberg JB, Powell KR, Stumpf WE, Breese GR. Autoradiographic analysis of the in vivo distribution of 3H-imipramine and 3H-desipramine in brain: comparison to in vitro binding patterns. Pharmacology, Biochemistry, and Behavior. 38: 621-31. PMID 2068199 DOI: 10.1016/0091-3057(91)90024-V  0.626
1991 Fremeau RT, Duncan GE, Fornaretto MG, Dearry A, Gingrich JA, Breese GR, Caron MG. Localization of D1 dopamine receptor mRNA in brain supports a role in cognitive, affective, and neuroendocrine aspects of dopaminergic neurotransmission. Proceedings of the National Academy of Sciences of the United States of America. 88: 3772-6. PMID 2023928 DOI: 10.1073/Pnas.88.9.3772  0.382
1991 Paul IA, Duncan GE, Mueller RA, Hong JS, Breese GR. Neural adaptation in response to chronic imipramine and electroconvulsive shock: evidence for separate mechanisms. European Journal of Pharmacology. 205: 135-43. PMID 1687466 DOI: 10.1016/0014-2999(91)90811-4  0.611
1991 Duncan GE, Little KY, Koplas PA, Kirkman JA, Breese GR, Stumpf WE. Beta-adrenergic receptor distribution in human and rat hippocampal formation: marked species differences. Brain Research. 561: 84-92. PMID 1665753 DOI: 10.1016/0006-8993(91)90752-H  0.388
1990 Duncan GE, Kaldas RG, Mitra KE, Breese GR, Stumpf WE. High activity neurons in the reticular formation of the medulla oblongata: a high-resolution autoradiographic 2-deoxyglucose study. Neuroscience. 35: 593-600. PMID 2381517 DOI: 10.1016/0306-4522(90)90331-W  0.327
1990 Paul IA, Duncan GE, Kuhn C, Mueller RA, Hong JS, Breese GR. Neural adaptation in imipramine-treated rats processed in forced swim test: assessment of time course, handling, rat strain and amine uptake. The Journal of Pharmacology and Experimental Therapeutics. 252: 997-1005. PMID 2157002  0.598
1990 Breese GR, Criswell HE, Duncan GE, Mueller RA. A dopamine deficiency model of Lesch-Nyhan disease--the neonatal-6-OHDA-lesioned rat. Brain Research Bulletin. 25: 477-84. PMID 2127238 DOI: 10.1016/0361-9230(90)90240-Z  0.346
1990 Duncan GE, Stumpf WE. High-Resolution Autoradiographic Imaging of Brain Activity Patterns with Radiolabeled 2-Deoxyglucose and Glucose Methods in Neurosciences. 3: 50-64. DOI: 10.1016/B978-0-12-185255-9.50008-0  0.329
1990 Stumpf WE, Duncan GE. [2] - High-Resolution Autoradiographic Mapping of Drug and Hormone Receptors Methods in Neurosciences. 3: 35-50. DOI: 10.1016/B978-0-12-185255-9.50007-9  0.315
1989 Stumpf WE, Heiss C, Sar M, Duncan GE, Craver C. Dexamethasone and corticosterone receptor sites - Differential topographic distribution in rat hippocampus revealed by high resolution autoradiography Histochemistry. 92: 201-210. PMID 2777639 DOI: 10.1007/Bf00500919  0.349
1989 Duncan GE, Stumpf WE, Breese GR, Mitra KE. Functional activity patterns in the forebrain of swimming rats: a 5 min 2-deoxyglucose study. Neuroscience Letters. 100: 111-6. PMID 2761758 DOI: 10.1016/0304-3940(89)90669-1  0.328
1989 Duncan GE, Oglesby SA, Greenwood RS, Meeker RB, Hayward JN, Stumpf WE. Metabolic mapping of functional activity in rat brain and pituitary after water deprivation. Neuroendocrinology. 49: 489-95. PMID 2725842 DOI: 10.1159/000125157  0.34
1989 Duncan GE, Brüstle O, Heiss C, Breese GR, Stumpf WE. Topographical assessment of accumulated radioactivity from [14C]2-deoxyglucose and [6(-14C)]glucose in rat forebrain at different survival periods. Neuroscience. 32: 813-22. PMID 2601848 DOI: 10.1016/0306-4522(89)90301-1  0.321
1989 Duncan GE, Paul IA, Powell KR, Fassberg JB, Stumpf WE, Breese GR. Neuroanatomically selective down-regulation of beta adrenergic receptors by chronic imipramine treatment: relationships to the topography of [3H]imipramine and [3H] desipramine binding sites. The Journal of Pharmacology and Experimental Therapeutics. 248: 470-7. PMID 2536433  0.606
1988 Brüstle O, Duncan GE, Hu W, Pilgrim C, Breese GR, Stumpf WE. Topography of basal glucose utilization in rat thalamus and hypothalamus determined with (1-14C)-glucose. Anatomy and Embryology. 179: 1-17. PMID 3213951 DOI: 10.1007/Bf00305095  0.319
1988 Paul IA, Duncan GE, Powell KR, Mueller RA, Hong JS, Breese GR. Regionally specific neural adaptation of beta adrenergic and 5-hydroxytryptamine2 receptors after antidepressant administration in the forced swim test and after chronic antidepressant drug treatment. The Journal of Pharmacology and Experimental Therapeutics. 246: 956-62. PMID 2843636  0.619
1988 Pertsch M, Duncan GE, Stumpf WE, Pilgrim C. A histochemical study of the regional distribution in the rat brain of enzymatic activity hydrolyzing glucose- and 2-deoxyglucose-6-phosphate Histochemistry. 88: 257-262. PMID 2835334 DOI: 10.1007/Bf00570281  0.327
1987 Duncan GE, Stumpf WE, Pilgrim C. Cerebral metabolic mapping at the cellular level with dry-mount autoradiography of [3H]2-deoxyglucose Brain Research. 401: 43-49. PMID 3815093 DOI: 10.1016/0006-8993(87)91161-9  0.346
1987 Duncan GE, Stumpf WE, Pilgrim C, Breese GR. High resolution autoradiography at the regional topographic level with [14C]2-deoxyglucose and [3H]2-deoxyglucose. Journal of Neuroscience Methods. 20: 105-13. PMID 3600030 DOI: 10.1016/0165-0270(87)90043-4  0.327
1987 Duncan GE, Criswell HE, McCown TJ, Paul IA, Mueller RA, Breese GR. Behavioral and neurochemical responses to haloperidol and SCH-23390 in rats treated neonatally or as adults with 6-hydroxydopamine. The Journal of Pharmacology and Experimental Therapeutics. 243: 1027-34. PMID 3121842  0.575
1985 Parvizi N, Sar M, Duncan GE, Stumpf WE. Autoradiographic determination of catechol estrogen binding sites in brain, pituitary and uterus Brain Research. 344: 373-376. PMID 4041885 DOI: 10.1530/Acta.0.109S006  0.368
1985 Duncan GE, Paul IA, Harden TK, Mueller RA, Stumpf WE, Breese GR. Rapid down regulation of beta adrenergic receptors by combining antidepressant drugs with forced swim: a model of antidepressant-induced neural adaptation. The Journal of Pharmacology and Experimental Therapeutics. 234: 402-8. PMID 2991500  0.601
1985 Paul IA, Duncan G, Breese GR, Mueller RA. Rapid elevation of TRH-like immunoreactivity (TRH-LI) by combined electroconvulsive shock (ECS) and imipramine (IMI) Federation Proceedings. 44: No. 2779.  0.516
1984 Duncan GE, Paul I, Mueller RA. Rapid down regulation of β-adrenergic receptors by the combination of swim stress and imipramine Federation Proceedings. 43: no. 3834.  0.526
Show low-probability matches.